Highmark Commercial Medical Policy - Pennsylvania |
Medical Policy: | L-191-002 |
Topic: | Intracellular Micronutrient Testing Panel |
Section: | Laboratory |
Effective Date: | November 13, 2017 |
Issue Date: | November 13, 2017 |
Last Reviewed: | January 2017 |
Intracellular micronutrient testing (also known as: micronutrient testing, essential metabolic analysis, leukocyte nutrient analysis, functional micronutrient analysis) is a novel lab panel that measures the intracellular level of multiple nutrients. Micronutrients measured by this test include but are not limited to the following: Vitamins- A, B1, B2, B3, B6, B12, C, D, K. E Biotin, Folate, Pantothenate, Minerals- Calcium, Magnesium, Manganese, Zinc, Copper Amino Acids- Asparagine, Glutamine, Serine Fatty acids, Oleic Acid Antioxidants -Alpha Lipoic Acid, Coenzyme Q10, Cysteine, Glutathione, Selenium Carbohydrate Metabolism- Chromium, Fructose Sensitivity, Glucose-Insulin Metabolism Metabolites- Choline, Inositol. Carnitine Total antioxidant function and immune Response Score (offered by SpectrCell Laboratories) |
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.
Policy Position Coverage is subject to the specific terms of the member’s benefit plan. |
Intracellular micronutrient testing panel is considered experimental/investigational. There is insufficient evidence in the published peer-reviewed medical evidence to support health outcomes or effectiveness of this test.
Place of Service: Outpatient |
Experimental/Investigational (E/I) services are not covered regardless of place of service.
The policy position applies to all commercial lines of business |
Denial Statements |
Services that do not meet the criteria of this policy will be considered experimental/investigational (E/I). A network provider can bill the member for the experimental/investigational service. The provider must give advance written notice informing the member that the service has been deemed E/I. The member must be provided with an estimate of the cost and the member must agree in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.
Links |
02/2017 New Policy Established For Intracellular Micronutrient Testing Panel